| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/26/2015 | US20150056165 Novel cyclosporin analogues for preventing or treating hepatitis c infection |
| 02/26/2015 | US20150056163 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/26/2015 | US20150056161 Regeneration of endogenous myocardial tissue |
| 02/26/2015 | US20150056160 Chemically induced intracellular hyperthermia |
| 02/25/2015 | EP2840134A1 Enzyme granules |
| 02/25/2015 | EP2840089A1 Cytokine receptor zcytor17 multimers |
| 02/25/2015 | EP2839843A1 VLA-1 antagonist for use in treating stroke |
| 02/25/2015 | EP2839743A1 Methods for treating psoriasis |
| 02/25/2015 | EP2839000A1 New process for the production and purification of the collagenase enzyme from vibrio alginolyticus |
| 02/25/2015 | EP2838913A1 Sodium channel sensitive conopeptides and analogs, including compositions and methods thereof |
| 02/25/2015 | EP2838912A1 Peptides for the binding of nucleotide targets |
| 02/25/2015 | EP2838910A1 Replication-competent vesicular stomatitis viruses |
| 02/25/2015 | EP2838553A1 Growth enhancement of infants |
| 02/25/2015 | EP2838552A1 Long-acting oxyntomodulin variants and methods of producing same |
| 02/25/2015 | EP2838551A1 Use of thymosin alpha for treatment of purulent rhinosinusitis |
| 02/25/2015 | EP2838550A1 Polymeric conjugates of c1-inhibitors |
| 02/25/2015 | EP2838549A1 Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease |
| 02/25/2015 | EP2838548A1 Hla class ii deficient cells, hla class i deficient cells capable of expressing hla class ii proteins, and uses thereof |
| 02/25/2015 | EP2838547A1 Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions |
| 02/25/2015 | EP2838546A1 Methods and compositions for treating wounds and reducing the risk of incisional hernias |
| 02/25/2015 | EP2838543A1 Immunostimulatory compositions and methods of manufacture |
| 02/25/2015 | EP2838511A1 Ocular drug delivery system |
| 02/25/2015 | EP2838506A1 Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
| 02/24/2015 | US8965709 Compositions and methods for treating growth hormone deficiency |
| 02/24/2015 | US8962818 Compositions comprising GHRH and GnRH and methods of using the same |
| 02/24/2015 | US8962817 Vectors encoding a paralytic peptide |
| 02/24/2015 | US8962813 Purification and use of a factor for supporting wound healing |
| 02/24/2015 | US8962811 Growth hormone and interferon-alpha 2 glycoproteins produced in plants |
| 02/24/2015 | US8962810 Macrocyclic heterocyclic compound for inhibiting hepatitis C virus and preparation and use thereof |
| 02/24/2015 | US8962801 Neisseria porin proteins |
| 02/24/2015 | US8962795 Factor H binding peptides and uses thereof |
| 02/24/2015 | US8962794 Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids |
| 02/24/2015 | US8962793 ErbB interface peptidomimetics and methods of use thereof |
| 02/24/2015 | US8962691 Retinoid replacements and opsin agonists and methods for the use thereof |
| 02/24/2015 | US8962666 Method for improving cartilage repair and/or preventing cartilage degeneration in a joint |
| 02/24/2015 | US8962633 Methods of treatment and prevention of metabolic bone diseases and disorders |
| 02/24/2015 | US8962590 Prostate cancer vaccine |
| 02/24/2015 | US8962572 Bortezomib formulations |
| 02/24/2015 | US8962571 Method for repairing DNA damage in keratinocytes |
| 02/24/2015 | US8962570 Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism |
| 02/24/2015 | US8962569 Compositions comprising spp24 peptide fragments |
| 02/24/2015 | US8962568 Treatment of T-cell mediated diseases |
| 02/24/2015 | US8962567 Eye drop composition for prevention and treatment of ophthalmic diseases containing fusion protein of FK506 binding protein |
| 02/24/2015 | US8962565 Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same |
| 02/24/2015 | US8962564 Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity |
| 02/24/2015 | US8962563 TFPI inhibitors and methods of use |
| 02/24/2015 | US8962562 Use of histones for therapeutic purposes |
| 02/24/2015 | US8962561 Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes |
| 02/24/2015 | US8962560 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases |
| 02/24/2015 | US8962559 Sustained release formulations comprising GNRH analogues |
| 02/24/2015 | US8962558 Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3 |
| 02/24/2015 | US8962557 Fibroblast growth factor mutants having improved functional half-life and methods of their use |
| 02/24/2015 | US8962556 FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof |
| 02/24/2015 | US8962555 PlGF-1 in homodimeric form |
| 02/24/2015 | US8962554 Oral insulin therapies and protocol |
| 02/24/2015 | US8962553 Method of treating a diabetic subject having a microvascular impairment disorder by a pegylated C-peptide |
| 02/24/2015 | US8962551 Quinoxalinyl derivatives |
| 02/24/2015 | US8962550 Identification of inhibitors of a bacterial stress response |
| 02/24/2015 | US8962548 Multi-component biological transport systems |
| 02/24/2015 | US8962547 Compositions comprising enzyme-cleavable oxycodone prodrug |
| 02/24/2015 | US8962546 Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses therefor |
| 02/24/2015 | US8962545 Enzyme treatment of foodstuffs for celiac sprue |
| 02/24/2015 | US8962320 Treating cardiovascular tissue |
| 02/24/2015 | US8962317 Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration |
| 02/24/2015 | US8962292 Capping-prone RNA polymerase enzymes and their applications |
| 02/24/2015 | US8962269 Spinal muscular atrophy diagnostic methods |
| 02/24/2015 | US8962034 Antiviral therapy with a whole, leech saliva extract |
| 02/24/2015 | US8962030 Nanoparticles for delivery of active agents |
| 02/24/2015 | US8962025 Rapidly acting dry sealant and methods for use and manufacture |
| 02/24/2015 | US8962015 Orally bioavailable lipid-based constructs |
| 02/24/2015 | US8961989 Methods for producing an immune response to tuberculosis |
| 02/24/2015 | US8961987 Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies |
| 02/24/2015 | US8961986 Peptide composition |
| 02/24/2015 | US8961981 Targeting the neuromuscular junction for treatment |
| 02/24/2015 | US8961971 Bispecific T-cell activator antibody |
| 02/24/2015 | US8961967 Antibody Fc mutants with ablated effector functions |
| 02/24/2015 | US8961962 Acid ceramidase and mammalian cell survival |
| 02/24/2015 | US8961961 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases |
| 02/24/2015 | US8961960 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
| 02/24/2015 | US8961959 Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| 02/24/2015 | US8961958 High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use |
| 02/24/2015 | US8961950 Neoadjuvant treatment of cancer with proleukin |
| 02/24/2015 | US8961928 Ligand and metal complex having the same |
| 02/24/2015 | US8961391 Systems and methods for delivery of a therapeutic agent |
| 02/24/2015 | US8960128 Topical anesthetic composition |
| 02/24/2015 | CA2749862C A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 02/24/2015 | CA2712078C Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor |
| 02/24/2015 | CA2705694C Inhibitors of malt1 proteolytic activity and uses thereof |
| 02/24/2015 | CA2702760C Insulin-like growth factor (igf) i mutant variants |
| 02/24/2015 | CA2650864C Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis |
| 02/24/2015 | CA2631491C Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 02/24/2015 | CA2614103C Additional arginines in vimentin polypeptides for diagnosing rheumatic diseases |
| 02/24/2015 | CA2489467C Humanized monoclonal antibody hpam4 |
| 02/24/2015 | CA2479288C Process for producing cytotoxic lymphocyte |
| 02/24/2015 | CA2467768C Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like loxl for stimulating the formation of elastic fibres |
| 02/24/2015 | CA2444907C Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5 |
| 02/19/2015 | WO2015023979A1 Discrete peg constructs |
| 02/19/2015 | WO2015023972A1 Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant |
| 02/19/2015 | WO2015023939A1 Compositions and methods for modulating expression of frataxin |
| 02/19/2015 | WO2015023898A1 Linear peptide antibiotcs |